- 全部删除
- 您的购物车当前为空
ML291 is a sufonamidebenzamide compound that induces the unfolded protein response (UPR) and overwhelms the adaptive capacity of UPR, resulting in apoptosis in various solid cancer models. It activates the PERK/eIF2a/CHOP apoptotic pathway of UPR and reduces leukemic cell burden [1].
为众多的药物研发团队赋能,
让新药发现更简单!
ML291 is a sufonamidebenzamide compound that induces the unfolded protein response (UPR) and overwhelms the adaptive capacity of UPR, resulting in apoptosis in various solid cancer models. It activates the PERK/eIF2a/CHOP apoptotic pathway of UPR and reduces leukemic cell burden [1].
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 591 | 5日内发货 | |
5 mg | ¥ 997 | 5日内发货 | |
10 mg | ¥ 1,810 | 5日内发货 | |
100 mg | ¥ 8,150 | 6-8周 | |
1 mL x 10 mM (in DMSO) | ¥ 1,090 | 5日内发货 |
产品描述 | ML291 is a sufonamidebenzamide compound that induces the unfolded protein response (UPR) and overwhelms the adaptive capacity of UPR, resulting in apoptosis in various solid cancer models. It activates the PERK/eIF2a/CHOP apoptotic pathway of UPR and reduces leukemic cell burden [1]. |
分子量 | 413.83 |
分子式 | C16H16ClN3O6S |
CAS No. | 1523437-16-2 |
密度 | 1.56 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容